CytomX Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
Go back to CytomX Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 3.19 +0.15 (4.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.04 | 52 Week High | $24.68 | |||
| Open | $3.04 | 52 Week Low | $9.10 | |||
| Day High | $3.22 | P/E | N/A | |||
| Day Low | $3.01 | EPS | $0.00 | |||
| Volume | 1,686,131 | |||||
